首頁 > 市場調查報告書 > 製藥

孤兒藥

市場調查報告書

商品編碼

1671873

鐮狀細胞疾病治療市場：依治療類型、年齡層、給藥途徑、最終用戶、分銷管道和地區

Sickle Cell Disease Treatment Market, By Treatment Type, By Age Group, By Route of Administration, By End User, By Distribution Channel, By Geography

出版日期: 2025年01月08日 | 出版商:

Coherent Market Insights | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025年全球鐮狀細胞疾病治療市場規模估計為 32億美元，預計到2032年將達到 88.1億美元，2025-2032年的年複合成長率為 15.6%。

報告範圍		報告詳細資訊
基準年	2024	2025年市場規模	32億美元
歷史資料	從2020年到2024年	預測期	2025 至2032年
預測期：2025-2032年年複合成長率：	15.60％	2032年價值預測	88.1億美元

圖表.2025年鐮狀細胞疾病治療市場佔有率（%），依地區

鐮狀細胞疾病是一種導致紅血球異常的遺傳性血液疾病。它會影響身體組織和器官的氧氣供應。此病在世界各地流行，尤其是撒哈拉以南非洲、中東、印度半島、地中海地區以及中美洲和南美洲。隨著診斷和檢測率的上升，以及對先進治療方案可用性的認知不斷提高，預計未來幾年市場將呈現豐厚的利潤機會。新藥和基於基因治療的治療方法的開發也刺激了市場擴張。

市場動態：

活性化的研究活動是全球鐮狀細胞疾病治療市場的主要成長要素。新興國家不斷增加的醫療支出和優惠的償付政策進一步推動了市場的成長。骨髓移植等治療方法的日益普及也推動了市場的發展。然而，先進治療方法的高成本和低度開發地區的低認知阻礙了市場的成長。基於基因治療的治療方法的日益普及對市場相關人員來說是一個巨大的機會。可負擔的再生治療方案的發展也有可能在不久的將來鋪平道路。

本研究的主要特點

本報告對全球鐮狀細胞疾病治療市場進行了詳細分析，並提供預測期（2025-2032）的市場規模和年複合成長率（CAGR%），假設2024年為基準年。

強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。

提供對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球鐮狀細胞疾病治療市場的主要企業根據公司亮點、產品系列、關鍵亮點、績效和策略等參數進行分析。

研究包括的主要企業包括Novartis AG、Emmaus Medical Inc.、Agios Pharmaceuticals Inc.、Bluebird Bio、Pfizer Inc.、Bristol-Myers Squibb Company、Celgene Corporation、GSK（GlaxoSmithKline）、Sanofi S.A.、Merck &Co.、Amgen Inc.、Bayer AG、Teva Pharmaceutical Industries Ltd.、Chugai Pharmaceutical Co., Ltd.、Daiichi Sankyo Company, Ltd.。

本報告提供的見解將幫助負責人和企業經營團隊未來的產品發布、升級、市場擴張和行銷策略做出明智的決策。

全球鐮狀細胞疾病治療市場報告針對該行業的各個相關人員，包括投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員將透過用於分析全球鐮狀細胞疾病治療市場的各種策略矩陣更輕鬆地做出決策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 3.20 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	15.60%	2032 Value Projection:	USD 8.81 Bn

Sickle cell disease is a genetic blood disorder causing abnormal red blood cells. It affects the oxygen supply to tissues and organs in the body. This disorder is prevalent across worldwide, especially in Sub-Saharan Africa, the Middle East, Indian subcontinent, Mediterranean regions, and South and Central America. With growing diagnostic and detection rates, coupled with rising awareness regarding availability of advanced treatment options, the market is projected to showcase lucrative opportunities over the coming years. The development of new drug therapies and gene-therapy based treatment approaches are also fueling the market expansion.

Market Dynamics:

Increasing research activities focusing on developing novel drugs and upcoming pipeline candidates are acting as a key growth driver for global sickle cell disease treatment market. Rising healthcare expenditures in emerging nations and favorable reimbursement policies are further supporting the market growth. Growing adoption of curative therapies such as bone marrow transplantation is also boosting the market. However, high costs associated with advanced treatment approaches and lack of awareness in underdeveloped regions are restraining the market growth. Rising adoption of gene-therapy based treatments presents significant opportunities for market players. Development of affordable regenerative treatment options also holds potential to create new avenues in the near future.

Key Features of the Study:

This report provides in-depth analysis of the global sickle cell disease treatment market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global sickle cell disease treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Novartis AG, Emmaus Medical Inc., Agios Pharmaceuticals Inc., Bluebird Bio, Pfizer Inc., Bristol-Myers Squibb Company, Celgene Corporation, GSK (GlaxoSmithKline), Sanofi S.A., Merck & Co., Inc., Amgen Inc., Bayer AG, Teva Pharmaceutical Industries Ltd., Chugai Pharmaceutical Co., Ltd., and Daiichi Sankyo Company, Ltd.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global sickle cell disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global sickle cell disease treatment market

Market Segmentation

By Treatment Type Insights (Revenue, USD Bn, 2020 - 2032)
- Blood Transfusion
- Bone Marrow Transplant
- Pharmacotherapy
- Hydroxyurea Therapy
- Oxbryta
- Adakveo
- Pain Management Drugs
- Others
By Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Adults
- Pediatric
- Geriatric
By Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Parenteral
By End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Homecare Settings
- Others
By Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Novartis AG
- Emmaus Medical Inc.
- Agios Pharmaceuticals Inc.
- Bluebird Bio
- Pfizer Inc.
- Bristol-Myers Squibb Company
- Celgene Corporation
- GSK (GlaxoSmithKline)
- Sanofi S.A.
- Merck & Co., Inc.
- Amgen Inc.
- Bayer AG
- Teva Pharmaceutical Industries Ltd.
- Chugai Pharmaceutical Co., Ltd.
- Daiichi Sankyo Company, Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Sickle Cell Disease Treatment Market, By Treatment Type
- Global Sickle Cell Disease Treatment Market, By Age Group
- Global Sickle Cell Disease Treatment Market, By Route of Administration
- Global Sickle Cell Disease Treatment Market, By End User
- Global Sickle Cell Disease Treatment Market, By Distribution Channel
- Global Sickle Cell Disease Treatment Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Driver
- Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global Sickle Cell Disease Treatment Market, By Treatment Type, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Blood Transfusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Bone Marrow Transplant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pharmacotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hydroxyurea Therapy
Oxbryta
Adakveo
Pain Management Drugs
Others

5. Global Sickle Cell Disease Treatment Market, By Age Group, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Sickle Cell Disease Treatment Market, By Route of Administration, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Parentral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Sickle Cell Disease Treatment Market, By End User, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Sickle Cell Disease Treatment Market, By Distribution Channel, 2020-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Sickle Cell Disease Treatment Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Treatment Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Emmaus Medical Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Agios Pharmaceuticals Inc.
Bluebird Bio
Pfizer Inc.
Bristol-Myers Squibb Company
Celgene Corporation
GSK (GlaxoSmithKline)
Sanofi S.A.
Merck & Co., Inc.
Amgen Inc.
Bayer AG
Teva Pharmaceutical Industries Ltd.
Chugai Pharmaceutical Co., Ltd.
Daiichi Sankyo Company, Limited